Araceli Biosciences Inc.
StreetZero Signal 64
About Araceli Biosciences Inc.
Araceli Biosciences Inc. is a privately held biotechnology company focused on accelerating drug discovery through innovations in high-content imaging and AI-driven analysis. Its flagship products include the Endeavor® system and Clairvoyance software. The company is headquartered in Portland, Oregon, and was spun out from Phoseon Technology. It operates in the Biotechnology Research industry with a website at www.aracelibio.com.
LATEST FUNDINGPrivate Placement
$2.5M
Announced 2026-11-03
TOTAL RAISED$11.2M
IN THE NEWS
- 🔗 Araceli Biosciences Inc.
- 🔗 Araceli Biosciences Closes $11.2M Seed Financing to Change the Pace of Drug Discovery - Araceli Biosciences
- 🔗 Araceli Biosciences - 2026 Company Profile, Funding & Competitors - Tracxn
- 🔗 Araceli Biosciences - 2026 Company Profile, Funding & Competitors - Tracxn
- 🔗 Araceli Biosciences raises $11.2M in Seed funding | This Week in Digital Health posted on the topic | LinkedIn
EMPLOYEES—
FOUNDED2020
HQPortland, Oregon, United States
Industry
Other Technology
Tags
BiotechnologyImagingAIDrug Discovery
Investors
Key highlights
- Closed $11.2M Seed round in April 2025 including SAFE conversions.
- Lead investor Bill Cortelyou serves as Board Chairman.
- Developing Endeavor system and Clairvoyance AI software for high-content imaging.
- Spun out from Phoseon Technology with focus on biomarker discovery tools.
- Headquartered in Portland, OR with 3,929 LinkedIn followers.
Tech stack
robot frameworkopencvseleniumplaywrightsalesforcejavascript
Ask StreetZero about Araceli Biosciences Inc.
Put our AI to work on this deal.
Similar companies
Other Other Technology deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account